PPARG and breast cancer: On the other hand, in Apcmin mice the same treatment increases the number of tumors, and the use of PPARγ inhibitors (including T0070907) suppressed breast cancer cell proliferation in vitro70 and restrained CRC cell migration and invasion both in vitro and in vivo71,72.